Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2025BMJ OpenOpen Access

Scoping review protocol of person- and patient-centred outcomes in cancer clinical trials: definitions and methodologies

View Full Paper
Ask AI
Bookmark
Share

Authors

MZMiguel Zambrano-LucioNPNirmala Bhoo PathySMSonia Menon

Discussion

Loading...

Member takes

Overview

Scoping review reveals trends and methodologies for assessing patient-centred outcomes in cancer treatment.

Key Points

  • To explore definitions and measurements of patient-centred outcomes in cancer clinical trials.
  • Conduct comprehensive searches in databases like PubMed and SCOPUS.
  • Include studies reporting patient-centred outcomes in cancer trials.
  • Screen studies independently by two reviewers following systematic review standards.
  • Use qualitative and quantitative synthesis for result analysis.
  • Identified ambiguities in definitions and methodologies for patient-centred outcomes.
  • Highlighted trends and gaps in existing literature regarding these outcomes.

Cite This Study

Zambrano-Lucio et al. (2025) studied this question.

synapsesocial.com/papers/69254f8ec0ce034ddc3599a3https://doi.org/10.1136/bmjopen-2025-100388
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Data collection methods for patient-reported outcome measures in cancer randomised controlled trials: a protocol for a rapid scoping review2024
  2. 2Scoping Review of Patient‐Centered Outcomes in Gastrointestinal Cancer Care2026
  3. 3Improving completion rates of patient-reported outcome measures in cancer clinical trials: Scoping review investigating the implications for trial designs2024 · 22 citations
  4. 4Outcome Reporting in Onco-Anaesthesiology and Perioperative Medicine2024
  5. 5Abstract B160: Assessing patient experience in cancer clinical trial participants: Results from a rapid umbrella review with an equity lens2024